Caption Management, LLC Karuna Therapeutics, Inc. Transaction History

Caption Management, LLC

  • $6.13 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$164.66 - $218.08 $1.3 Million - $1.72 Million
7,900 New
7,900 $1.34 Million
Q3 2022

Nov 14, 2022
BUY
$123.79 - $277.42 $437,226 - $979,847
3,532 New
3,532 $794,000
Q4 2021

Feb 11, 2022
SELL
$110.64 - $159.4 $188,088 - $270,980
-1,700 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$101.2 - $125.87 $172,040 - $213,979
1,700 New
1,700 $208,000

Others Institutions Holding KRTX

# of Institutions
10
Shares Held
332K
Call Options Held
0
Put Options Held
0
View Full List

About Karuna Therapeutics, Inc.

KRTX Quotes by TradingView
  • Ticker KRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,965,000
  • Description
  • Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...
More about KRTX
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email